T-cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous disease that targets lymphoid T cells during their differentiation in the thymus. 1 Numerous pathways have been described as altered in T-ALLs and the actual idea is that at least four different pathway alterations, such as overexpression of transcription factors, activation of receptors or deregulation of cell cycle mediators, are necessary to induce leukemic progression. 2 Controlling the expression of altered pathways in leukemic blasts, in order to understand their implication in the transforming process and analyze the molecular consequences of deregulated expression, is greatly limited by our poor knowledge on conditions of survival and stimulation of such abnormal T cells. So far, most functional studies have been performed using long-term maintained in vitro cell lines originally derived from patients or mouse transgenic models that do not systematically reproduce the human biological situation. Few functional data are yet available on primary T-ALL patient samples, mostly related to the lack of available experimental assays allowing long-term growth and sustained leukemia development. Transduction of normal T cells has been difficult to achieve, particularly naive or quiescent T cells. However, this can now be overcome owing to the development of lentiviral particles pseudotyped with heterologous proteins, such as receptor ligands or cytokines. 3 Our study explores conditions for efficient activation and lentivectors (LVs) transduction of blasts from T-ALL patients. We used LV-pseudotyped particles with the interleukin-7/murine leukemia virus chimeric glycoproteins (G/IL-7SUx) that were previously shown to improve normal T-cell transduction. 4 Indeed, many T-ALL are positive for IL-7Ra/CD127 expression 5 and thus G/IL-7SUx-pseudotyped LVs are good candidates for T-ALL gene transfer. In control experiments, we showed that G/IL-7Sux-and VSV-G-pseudotyped LVs allowed a similar transduction of human thymus CD34 þ cells, whereas umbilical cord blood (UCB) CD34 þ cells were preferentially transduced with VSV-G-pseudotyped particles (Supplementary Figure 1) . Increasing multiplicity of infections (MOIs) of G/IL-7SUx LVs did improve transduction of CD34 þ cells from the thymus, but not from UCB, correlating with the level of IL-7Ra/CD127 expression in thymic CD34 þ (IL-7Ra þ ) and in UCB CD34 þ (IL-7RaÀ) cells. 6, 7 To perform human T-ALL transduction, thawed blasts were precultured with MS5 cells engineered to express the NOTCH ligand Delta-like-1 (MS5-DL1) to activate live cells and get rid of dead cells (see Supplementary Methods for experimental details and Supplementary Table for details on T-ALL samples). Live blasts were then transduced during 48 h with VSV-G-or G/IL7SUx-pseudotyped vectors, either in the presence or absence of rIL-7 ( Figure 1a) . Results show that IL-7-nonstimulated T-ALL cells are weakly transduced (3.5±1.1% enhanced green fluorescent protein positive (EGFP þ )) with VSV-G-pseudotyped vectors, whereas usage of vector particles pseudotyped with the G/IL7SUx envelop improved levels of gene transfer (9.5 ± 1.1% EGFP þ ). Interestingly, addition of rIL-7 during transduction increased mean fluorescence intensities of transduced cells and moderately enhanced transduction efficiency for VSV-G viral construct, whereas it did not for G/IL-7SUx-pseudotyped vectors ( Figure 1a, left panel) . IL-7-displaying vectors induced cell stimulation as reflected by the increase in cell size. The percentage of activated cells was between 17 and 20% in the presence of rIL-7 with or without LV particles, whereas only 1% of cells displayed increased cell size without rIL-7 ( Figure 1a , right panel). Transduction with G/IL-7SUx-pseudotyped vectors resulted in 8% of cells with increased cell size, indicating that G/IL-7SUx/LV particles were able to activate T-ALL in the absence of rIL-7, although to a lesser extent than conditions with rIL-7. This result is in accordance with previous data showing that G/IL-7SUx vectors were as potent as rIL-7 to promote T-cell activation, 4 but suggest here that the quantity of IL-7 carried by the vector particles was inferior to the 10 ng/ml of rIL-7 added in the culture. Interestingly, large cells were more transduced than small cells, further suggesting that T-ALL activation is crucial to improve transduction efficiency ( Figure 1b and Supplementary Figure 2 ). To further optimize gene transfer, LVs and target T-ALL cells were spinoculated in the presence of protamine sulfate. In these experiments, we included a comparison of EGFP expression levels obtained with three different promoters, elongation factor 1-alpha (EF1-a), modified myeloproliferative sarcoma virus (MND) and spleen focus forming virus (SFFV). Improved transduction (1.3-2 Â ) and transgene expression (1.9-2.5 Â ) levels were observed for all constructs tested when cells were spinoculated and the SFFV promoter provided the highest transgene expression as evidenced by mean fluorescence intensity values ( Figure 1c ). The reason why the MND/LV construct gave rise to the highest transduction levels is currently not understood as the same MOI of different LV construct productions was used to transduce T-ALL. However, it might be attributed to the quality of different LV construct productions that depend on several factors (including plasmid preparation, confluence of producer cell lines, and so on) leading to variable transduction efficiency of patient samples. Such problem would not be evidenced when using cell lines such as Jurkat cells that are easy to transduce, underlining that extension of cell lines data to primary cells should be carried out with caution.
Using co-culture of human T-ALL with MS5-DL1 cells, our group has recently shown that activation of the NOTCH pathway promotes long-term proliferation of human T-ALL cells and maintenance of leukemia-initiating activity. 8 However, MS5 cells are highly permissive to lentiviral transduction (Supplementary Figure 3) and cannot be used in T-ALL transduction experiments. To keep T-ALL activation during transduction, we thought to substitute MS5-DL1 cells with plastic-bound human DL1 (Ig-DL1), which was shown to maintain NOTCH activation in human hematopoietic stem cells. 9 This seems particularly important when performing gene transfer with IL-7SUx/G-pseudotyped LVs, as recently published results showed that IL-7Ra chain expression is regulated by the NOTCH/CSL/MALM pathway. 6 Our results indicate that Ig-DL1 can indeed activate T-ALL proliferation (Figure 1d and Supplementary Figure 4) . These results led us to propose a protocol that ensures the activation and cell survival during gene transfer into T-ALL (Figure 1e and Supplementary Methods). Using this protocol, we could reproducibly transduce T-ALL from different samples (Figures 2a and b) and EGFP þ and EGFP -populations showed similar CD7, CD4 and CD8 expression (10 6 cells/ml) during 48 h with MS5-DL1 cells followed by filtration and adhesion of MS5-DL1 cells. Blasts were then centrifuged ( þ spinoculation) or not (Àspinoculation) at 1500 g during 2.5 h at 20 1C in the presence of protamine sulfate (5 mg/ml), rIL-7 (10 ng/ml) and G/IL-7SUx LVs at MOIs of 30. EGFP expression driven by EF1-a, MND or SFFV internal promoters was evaluated using FACS analysis. MFIs are shown in the table. (d) Blasts (M53 T-ALL) were cultured in contact with Ig-DL1 at 0.5 and 2.5 mg/ml during 21 days in the presence or absence of gamma secretase inhibitor (GSI) (10 mM). Cell proliferation was assessed by 5-bromodeoxyuridine (BrdU) incorporation and 7-Aminoactinomycin D (7-AAD) (for details see Supplementary Methods) and analyzed by FACS. (e) Design of the transduction protocol: Fresh or thawed T-ALL samples at diagnosis or after xenografts are co-cultured during 48 h on MS5-DL1 in complete T-ALL medium as a pre-activation step. 8 After filtration and adhesion of MS5-DL1 cells, blasts are spinoculated during 2 h in the presence of Ig-DL1 (2.5 mg/ml), 5 mg/ml protamine sulfate and G/IL-7SUx-pseudotyped MND/EGFP LVs. Transduction further proceeds during 48 h at 37 1C, and EGFP expression driven by the MND promoter is assessed using FACS analysis after careful wash of the cells. EGFP þ blasts can be then sorted and used in functional assays.
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LV transduction protocol maintains in vitro proliferation properties of T-ALL and in vivo human T-cell leukemia-initiating cell (T-LIC) activity, transduced T-ALLs, sorted for EGFP expression, were cultured on MS5 and MS5-DL1 stromal cells or were injected into immunodeficient NOD.CB17-Prkdc(SCID) (NOD-SCID) and NOD.Cg-Prkdc(scid)Il2rg(tm1Wjll)/SzJ (NSG) mice. 10 Transduced T-ALL cells were capable of in vitro proliferation on NOTCH activation. Sorted CD7
þ EGFP þ T-ALL expanded on MS5-DL1 but not on MS5 cells, resulting in a 20-fold cell number increase during culture as obtained previously with untransduced T-ALL, 8 although maintaining transgene expression through the MND promoter (Figure 2c ). Transduced T-ALL samples engrafted NOD-SCID and NSG mice and EGFP remained expressed in more than 90% of engrafted leukemic CD45 þ CD7 þ blast cells (Figures 2d and e) . Moreover, EGFP þ CD7 þ blasts and for the proportion of transduced blasts using EGFP expression. (e) Representative example of human leukemic transduced T-ALL engraftment of the BM of primary and secondary NSG mice analyzed 6 weeks after transplantation. M18 T-ALL was used in this experiment.
Letters to the Editor recipient mice indicating the presence of T-LIC activity. In one experiment, we assessed the influence of T-ALL gene transfer on T-LIC activity. The results showed no difference between untransduced and transduced T-ALL cells in NSG mice engraftment and suggested that the transduction protocol does not spoil T-LIC activity (Supplementary Figure 5) . Altogether, these results show that efficient gene transfer is now feasible in primary T-ALL samples, although keeping in vitro proliferation and in vivo T-LIC activity. Thus one can now manipulate gene expression in primary human T-ALL samples and address the role of specific oncogenic proteins in leukemogenesis and in the biological activity of T-LIC. In a recent study, we have efficiently decreased SCL/TAL1 protein expression using this protocol and showed a major effect of such manipulation on the proliferation of TAL1-expressing T-ALL. 11 These newly developed conditions thus open a large field of investigation of the molecular pathways implicated in human T-ALL.
